Equity Profile
Pre-Earnings Brief
Schein Henry Inc (HSIC) is a healthcare distributor that supplies a wide range of medical and dental products. With a market cap of $9 billion, the company plays a crucial role in the healthcare supply chain, especially as demand for healthcare services continues to grow.
Earnings Per Share (EPS)
EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Revenue
Revenue figures provide insight into the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
2Q
EPS Beat Rate
75%
Avg EPS Surprise
+3.16%
Avg Stock Reaction
-0.30%
In Q4-2025, Schein Henry reported an EPS of $1.34, exceeding expectations by 3.08%. The stock reacted positively, gaining 3.45% the following day.
Management Promises & Guidance
Analysts expect Schein Henry to report solid earnings this quarter, with a consensus EPS of $1.22 and revenue of $3.3 billion. The company has a strong track record of beating earnings estimates.
Bull Case
If Schein Henry meets or exceeds the EPS estimate, it could signal strong demand and operational efficiency, potentially leading to a positive stock reaction.
Bear Case
Conversely, if the company misses the EPS target, it may raise concerns about its growth prospects and operational challenges, leading to a negative market reaction.
Earnings Per Share (EPS)
$1.22EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Revenue
$3.3BRevenue figures provide insight into the company's sales performance and market demand for its products.
Expectations
The print will turn on these two things.
Q1
Will the EPS exceed the consensus estimate of $1.22?
A beat on EPS would reinforce investor confidence and could lead to a positive stock reaction.
Q2
What are the revenue figures compared to the consensus of $3.3 billion?
Revenue performance is critical for assessing the company's growth and market demand, impacting investor sentiment.
Edge
Why consensus could be wrong
The consensus may underestimate the potential for Schein Henry to exceed EPS expectations due to strong demand in the healthcare sector.
Supporting Evidence
The company has consistently beaten EPS estimates in 88% of the last quarters.
Options pricing suggests a lower expected move compared to historical averages, indicating potential for a surprise.
Key Risk
If revenue significantly exceeds $3.3 billion, it could invalidate the cautious outlook and drive the stock higher.
Edge
Pre-commit to what would confirm each case.
The market is weighing the company's ability to maintain growth amidst evolving healthcare demands.
Bull Confirmed If
An EPS of $1.25 or higher would confirm strong operational performance and demand.
Bear Confirmed If
An EPS below $1.16 would indicate potential challenges in meeting market expectations.
Pre-Earnings Positioning
Implied Move
±3.98%
Historical Avg
±5.3%
The options market is pricing in a modest move around the earnings report, suggesting that investors are uncertain about the outcome.
Options are pricing ±4.0% while HSIC has averaged ±5.3% over the last 8 prints — setup is pricing cheap.
30d HV
20.0%
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Schein Henry beats expectations, history suggests the stock could rise by around 0.72%, confirming strong demand and operational efficiency.
In-Line / Cautious
If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.
Miss
A miss on earnings could lead to a decline of about 7.41%, raising concerns about the company's growth trajectory.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
LOEWS CORP